Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03284346 · ClinicalTrials.gov registry record · NA
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors
A NA study, sponsored by University of Southern California.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT03284346 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 23 participants.
The verdict
NCT03284346, a NA study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies how well circuit, interval-based aerobic and resistance exercise works in targeting metabolic dysregulation in stage I-III breast or prostate cancer survivors. Circuit, interval-based aerobic and resistance exercise may help to improve cardiovascular fitness, weight loss, healthy lifestyle behaviors, and muscle strength in breast or prostate cancer survivors.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Laboratory Biomarker Analysis
- BEHAVIORAL Exercise Intervention
- OTHER Polar heart rate monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-08-17 |
| Est. Completion | 2019-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03284346
The ClinicalTrials.gov registry entry for NCT03284346 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT03284346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03284346 about?
NCT03284346 is a clinical study titled "Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors". This randomized pilot clinical trial studies how well circuit, interval-based aerobic and resistance exercise works in targeting metabolic dysregulation in stage I-III breast or prostate cancer survivors. Circuit, interval-based aerobic and resistance exercise may help to improve cardiovascular fitn...
What is the current status of trial NCT03284346?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2017-08-17. Estimated completion is 2019-07-15.
What interventions are being tested in trial NCT03284346?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Laboratory Biomarker Analysis (OTHER), Exercise Intervention (BEHAVIORAL), Polar heart rate monitor (OTHER).
Who is sponsoring clinical trial NCT03284346?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.